We are delighted to have been shortlisted in the ‘Best Technology’ category at the @EuromedEvent #EMA25

Today we announced a new #partnership with the NHS Vaccine Launch Pad to fast-track patients into the fourth cohort of our ongoing Phase 2 SCOPE study of next generation #CancerVaccine iSCIB1+ in advanced #melanoma. Learn more here: scancell.co.uk/wp-content/up…

On 28 April, our CMO, Nermeen Varawalla, will be presenting #ClinicalData from our ongoing Phase 2 SCOPE trial of lead #CancerVaccine SCIB1/iSCIB1+ at #AACR25. To learn more, read the full research here: scancell.co.uk/wp-content/up… #Biotech #Immunotherapy

Our CEO, Phil L’Huillier, will be speaking on in a #panel on 3 April at the Anglo-Nordic #LifeScience Conference. Join ‘What’s Next in Immunology’ at 9:15AM BST to hear about the key trends shaping the field, including more on our innovative 'off-the-shelf' DNA #Cancer Vaccines.

Our CMO, Dr Nermeen Varawalla, will be attending the #IO360 Summit in Boston on 24-26 March where she’s excited to be discussing our pipeline of ‘off-the-shelf’ cancer vaccines with fellow leaders in the immuno-oncology space.

Join us at #NextGenBiomed! Callum Scott our Head of Development moderates 'Benchmarking Vaccine Platforms', Wed 14:45, and Elisa Marell our Senior Scientist will present a poster on DNA cancer vaccine potency assay, Fri 16:20. To meet, contact [email protected]

Joseph Chadwick, Translational Research Scientist, will be presenting safety and efficacy data from our Phase 2 SCOPE study in advanced #melanoma at #AACRIO25. Join him from 1:45-4:45PM PT to learn more. Read the full press release: scancell.co.uk/news/ #CancerVaccine

Today is #WorldCancerDay, a time to reflect on the resilience of cancer patients around the globe and look to the future of care and treatment for this most pervasive disease.

Tomorrow, following the announcement of our interim results, our CEO Phil L'Huillier and CFO Sath Nirmalananthan will host a live webcast and Q&A session at 14:00 GMT. To join: lsegissuerservices.com/spark…

X In the second instalment of @PharmaScrip’s annual #ScripAsks series, our CEO, Phil L’Huillier, shares his thoughts on the #funding and #partnering trends that are likely to shape the #biopharma industry in 2025. For more: insights.citeline.com/scrip/… #Biotech #ThoughtLeadership

Our CEO, Phil L'Huillier, and Head of Business Development, Mandeep Sehmi, are attending #JPM25. If you are also attending and would like to learn more about our ‘off the shelf’ #CancerVaccine programmes, get in touch via [email protected] to set up a meeting.

Dr Nermeen Varawalla, CMO, will be in Geneva from 11-13 December to attend the @myESMO Immuno-Oncology Congress 2024. To set up a meeting with her, contact us at [email protected]. #ESMOImmuno24 #CancerVaccine #ImmunoOncology #Biotech

Our Head of Business Development, @Mandeep Sehmi, is attending #BIOEurope taking place from 4-6 November in Stockholm. If you would like to get in touch, please reach out via [email protected]

On 16 October, Samantha Patson will discuss our novel #CancerVaccine approach, including the latest updates on our SCOPE and MODI studies, in a presentation at the @festofbiologics. For more information: terrapinn.com/conference/fes… #Biotech #ImmunoOncology

We are excited to announce that our CEO and CSO, Professor Lindy Durrant, has been shortlisted as a finalist for the ‘Executive of the Year – Clinical-Stage Companies’ category at the @PharmaScrip #Awards 2024! We wish the best of luck to all finalists! #Oncology #CancerVaccine

Our CMO, Dr Nermeen Varawalla, and Medical Director, Dr Robert Miller, will be attending @myESMO Congress 2024 in Barcelona, Spain from 13-17 September. To arrange a meeting with either Dr Varawalla or Dr Miller, please reach out to [email protected] #ESMO24

Next week, Mandeep Sehmi, Head of Business Development at Scancell, will be in Boston for the ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit. To arrange a meeting with Mandeep, reach out to [email protected]. #CancerVaccine #Oncology #Biotech

Our CFO Sath Nirmalananthan is attending the @CG_Driven Annual Growth Conference from 13-15 August in Boston, MA. To arrange a meeting, reach out to [email protected]. #CancerVaccines #Investors #Biotech #ImmunoOncology #Oncology

Great to see Scancell featured in an article by @GENbio discussing the evolution and resurgence of cancer vaccines. Our CEO, Lindy Durrant also explains the benefits of Scancell’s novel ‘off-the-shelf’ cancer vaccine approach. genengnews.com/topics/infect…

We’re delighted to announce that @Nermeen Varawalla has been appointed as Scancell’s Chief Medical Officer, bringing over 25 years of senior leadership experience in the healthcare industry. Find out more at: scancell.co.uk/scancell-appo… #Appointment #CMO #CancerVaccines